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Abstract
About 23 million people, including almost 10 million children, have asthma in the United
States. Asthma prevalence is higher among families with lower incomes living at the US/
Mexico Border and represents the most common serious chronic diseases of childhood. It is the
third-ranking cause of hospitalization among children under 15, (De Frances, 2007) as well as
the cause of seven million physician visits and nearly 200,000 hospitalizations every year. An
average of one out of every ten school-aged children has asthma and, 13 million school days are
missed each year due to asthma symptoms (Akinbami, 2006). According to the National Heart,
Lung, and Blood Institute (NHBLI, 2009) annual expenditures for health and lost productivity
due to asthma are estimated at over $20 billion. Recently, research has shown that low serum
levels of Vitamin D might be associated with poor asthma control (Bhrem, 2010), but the exact
mechanism is still unknown. Studies about the potential effect of vitamin D are largely based on
observational studies that lack measurements of serum levels.
This dissertation used National Health and Nutrition Examination and Survey
(NHANES) data from 2005-2006 to examine the relationship between vitamin D, asthma and
allergy among 1884 U.S. children age 6-15. Data from 2005-2006, included serum levels of
vitamin D [25(OH) D], questionnaires of asthma and allergy symptoms, sociodemographic
characteristics, and assays for total and allergen-specific IgE. A mediation analysis was
performed to explore the mediation effect of IgE between the relationship of vitamin D and
asthma symptoms.
The prevalence of asthma observed in this cross-sectional study was 16.3% .The
majority of study children (86%) had serum vitamin D levels below an accepted optimal
threshold < or =30 ng/mL, with mean ± SDs of 22.13 ± 7.8 ng/mL.
vi

The risk of asthma diagnosis was higher among children with deficient serum levels of
25(OH) D compared with children with sufficient vitamin D status (OR, 1.53; 95% CI, 1.002.33). Similarly, allergy diagnosis was associated with vitamin D deficiency (OR, 1.58; 95% CI
(1.10-2.27) in a multivariate model adjusted for age, gender, parental education and BMI.
The mediation analysis showed that vitamin D was negatively related to asthma severity
and that Immunoglobulin E [IE= -.013, 95% CI [-.023,-005] mediated this relationship. Gender
moderated this relationship such that these associations were stronger for boys than for girls.
Overall, the results suggest that addressing reduction of vitamin D deficiencies could be a
potential public health strategy to decrease asthma and allergy severity in children
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Chapter 1: Introduction

Asthma is a chronic disease characterized by episodes of impaired breathing and recurrent
attacks of breathlessness and wheezing. Over 10 million U.S. children under 18 years of age
were diagnosed with asthma in 2009 (CDC, 2010). Asthma prevalence is higher among families
with lower incomes living along the US/ Mexico Border. Asthma represents the most common
serious chronic diseases of childhood and it is the third-ranking cause of hospitalization among
children under 15 years of age (De Frances, 2007), the cause of seven million physician visits,
and nearly 200,000 hospitalizations per year. An average of 1 out of every 10 school-aged
children has asthma, and, according to the National Health Interview Survey, 10 million school
days were missed during 2008 due to this disease (Akinbami, 2011). In addition, the National
Heart, Lung, and Blood Institute (NHBLI, 2009) reported over $20 billion annual expenditures
for health and lost productivity due to asthma.
Although the role of vitamin D in bone health is well known, recent studies have described
new, nonskeletal roles for vitamin D in human health, including a role in asthma (Black, 2005,
Burns 2006, Camargo, 2007). Litonjua and Weiss (2007) recently offered a new hypothesis to
explain the increase of asthma prevalence. They hypothesized that vitamin D among pregnant
women influences the development of asthma in their offspring. Whether vitamin D status is
associated with asthma in children remains unclear. The overall objective of the proposed study
is to examining whether vitamin D serum levels are associated with asthma symptoms, asthma
exacerbations, and allergic immune response in a representative national sample of children in
United States using data collected from the National Health and Nutrition Examination Survey
(NHANES) 2005-2006.

1

This project proposes a series of analysis examining:
a) The association of asthma diagnosis and serum levels of 25-Hydroxyvitamin D3 [25(OH)
D] which is an indicator of vitamin D status among children between 6 and 15 years old.
b) The association between serum levels of 25(OH) D and asthma symptoms and allergic
sensitization.
c) Weather Immunoglobulin E serum levels were a potential mediator of vitamin D status
and asthma.
The outcome of the proposed study will be to provide information that can be used to
design strategies for tailored public health intervention to improve asthma control, possible by
vitamin D supplementation and/or moderate increases in sun exposure. The long term goal is
increase the understanding of the association between vitamin D, allergic sensitization and
asthma symptoms.

2

Chapter 2. Literature Review

Asthma
Asthma definition. Asthma is a chronic disorder of the airways characterized by airway
inflammation, airflow obstruction, and an exaggerated bronchoconstriction response to a variety
of stimuli. When airways are exposed to various allergens or triggers, an inflammatory immune
response is activated leading to airway obstruction. The muscles that surround the airways
contract and tighten (commonly known as bronchospasm) and, the production of mucus
increases, leading to mucus plugs. In addition, the airways become sensitive to allergens like
pollens, mites, molds or food, and irritants such as cold air, smoke, and air pollutants. All of
these factors cause the airways to narrow, thus making it difficult for air to go in and out of the
lungs, causing the recurrent symptoms of asthma such as cough, wheeze and shortness of breath
(GINA,2012)
Airway inflammation and atopy .The cause of asthma is not completely known, but it
reflects a complex expression of genetic factors (atopy) and environmental exposures (e.g.,
airborne allergens, viral infections, irritants exposure like tobacco smoke, air pollution).
Inflammation plays a central role in the pathophysiology of asthma and involves the interaction
of different cell types including T lymphocytes, mast cells, eosinophil, epithelial cells, and
macrophage. Also the constituent airway cells, such as fibroblasts, endothelial cells, and
epithelial cells participated in the cascade of airway inflammation. (NHBLI, 2008)

3

Traditionally, airway inflammation in asthma had been presented as an imbalance
between two populations of Th (Timo helper) lymphocytes: Th1 and Th2. The lymphocytes are
one type of leucocytes that are produce by stem cells in the bone marrow. The main types of
lymphocytes are B (bone cells) and T (thymus cells). B cells control infections by stimulating the
humoral immunity and producing antibodies, whereas T lymphocytes are involved in cell
mediated immunity. If an antigen is detected, a specific T cell, named T helper (Th), will
produce cytokines which are various proteins that serve to regulate the immune system by
attracting other T cells. Depending of the antigen presented, Th1 or Th2 will be activated. If the
antigen is an infection agent (virus, bacteria etc.) , the Th1 cells will produce interleukin (IL)-2
and interferon (IFN-α) as a cellular defense mechanism. In contrast, if the antigen is an allergen,
the Th2 will produce cytokines and Immunoglobulin E (IgE) that will results in an allergic
reaction.
Previous studies suggested the possibility that chronic allergic inflammation and the
development of asthma might be the result of loss of normal immune balance by an exaggeration
of T-helper type 2 (Th2) over Th1 responses (Gern, 2002; Eder, 2006; Akabari, 2006). For a long
time, asthma has been considered to be a T- helper2 (TH2)-cell driven inflammatory disease
(Robinson et al., 1992). Recently, Lloyd and Hessel (2010) reported that other factors that
damage the pulmonary epithelium, including pathogens, air pollution and allergen will increase
the production of another type of cytokines such as IL-33, IL-25 which are able to promote the
development of Th-2 lymphocytes. Thus airway inflammation has a central role in the
pathophysiology of asthma and involves an interaction of many cells .The process by which this
interaction results in asthma symptoms are still under investigation.

4

The sequence of events for the inflammation response is shown in Figure 1. In all cases,
antigens or “non-self” substances encounter into the lungs dendritic cells that line the airway.
These dendritic cells or Antigen Presenting Cells (APCs) then migrate to the lymph nodes where
the intruder is presented to T and B cells. The B-cells induced the production of Immunoglobulin
E (IgE ) which binds to receptors on the surface of mast cells. Usually the substances that are
foreign to the body and can cause an allergic reaction (allergens) will increase IgE levels that
will stimulate mast cells and eosinophils (Dodig, Richter, & Zrinski, 2011). When the allergen
interacts again with the mast cells, an activation and degranulation occurs releasing histamine
and leukotrienes, and causing bronchocospasm that results in airway obstruction. Also, the
airway is infiltrated by Th2cellsproducing cytokines (IL-4, IL-5, IL-8, and IL-13) which will
activated eosinophils, basophils, the production of Immunoglobulin E (IgE) and will directly
secretes mediators like histamine, prostaglandins, leukotrienes, and tryptase. These cytokines
will stimulate also mast cells causing leukocytosis, eosinophilia ,vascular leakage, bronchial
smooth muscle contraction ,mucus hypersecretion, airway hyperresponsiveness (AHR) and
ultimately airway remodeling. This inflammation and bronchoconstriction result in recurrent
episodes of cough, wheeze and shortness of breath (Verstraelen, Bloemen, Witters, Schoeters, &
Van Den Heuvel, 2008).
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Figure1. Overview of inflammation cascade in asthma. Modified from Verstraelen (2008).[Fig.
overview of the allergic cascade]. Toxicology in Vitro

Assessment of asthma . To establish a diagnosis of asthma, the clinician should
determine that a) episodic symptoms of airflow obstruction or airway hyper responsiveness are
present; b) airflow obstruction is at least partially reversible and; c) alternative diagnoses are
6

excluded.(NHLBI, 2008) Asthma is a complex disease, according to the Global Initiative for
Asthma (GINA), the basis of asthma treatment is the careful assessment of disease severity and
control to guide treatment and thus prevent exacerbations and asthma progression. Asthma
“severity” can be considered as the intrinsic intensity of the disease and asthma “control” is the
degree to which the manifestations of the disease (i.e., symptoms, functional impairments, and
risk of exacerbations) are minimized by treatment, (GINA ,2012)
Advances in science have led to an increased understanding of asthma and its mechanisms as
improved treatment approaches. Main components that influence effective asthma management
include use of objective tools to assess asthma severity, control of environmental factors that
could precipitate asthma exacerbations, improvement of patient and family education, and
pharmacology therapy to prevent and reverse airway inflammation (NAEPP, 2007).
Asthma at US / Mexico Border. The US-Mexico Border region is defined as that region
extending 100 kilometers (62.5 miles) North and South of the international boundary. It
stretches approximately 2,000 miles from southeast Texas to the California coast. The TexasMexico Border region extends 1,254 miles from El Paso-Ciudad Juarez to BrownsvilleMatamoros with an estimated population of 4.1 million people living in 32 border counties. The
predominant ethnicity is Hispanic at 87.4% primary of Mexican origin, non-Hispanic white
10.3%, African American 1.1%, and Asian, Native American, or other race/ethnicities at 1.2 %
(Lakey, 2009).
Prevalence of asthma varies by race and ethnicity. Specifically, asthma prevalence is
reported at 5.8% for Hispanics, 7.8% for non-Hispanic whites, and at 10.3% for African
Americans (CDC, 2010). Even though the reported prevalence of asthma among Hispanics is
lower compared with other ethnicities, trends for asthma mortality in the U.S. (approximately
7

5,000 deaths annually) have shown a progressive increase over the last 2 decades, with the high
mortality rates seen among minority populations including Hispanics (Masoli, 2004). Concern
has been raised that asthma may be under diagnosed, particularly among minority children who
have more restricted access to high quality health care. In addition, Hispanic children are more
likely to experience poor asthma control compared with non-Hispanic white children. For
example Crocker (2009), in a multistate asthma survey, reported that Hispanic children
underused daily controlled medication and increased emergency health care compared with white
children.
Previous studies conducted along the Texas US/Mexico border have shown that the
social, environmental, economic, and cultural circumstances of racial and ethnic minority
Hispanic groups have increased the vulnerability to uncontrolled asthma. For example Grineski
(2007) showed that the rates of asthma hospitalizations for children were 36% higher on the
Texas US/Mexico border than they were in the rest of Texas. Other studies have shown that the
vulnerability of children to uncontrolled asthma is higher in the border region than it is in other
parts of Texas (Heyman, 2007; USMBHC, 2007).

Role of nutrients in asthma. During the past two decade researchers have shown a
growing interest in the potential protective role of various dietary components including
antioxidants, fish and magnesium on the risk of developing asthma and the reduction of asthma
symptoms .The potential role of diet in asthma was first described by Seaton in 1994, who first
hypothesized a potential association between changes in diet during the last decades
(Westernization) with rise in asthma prevalence. The ‘Western’’ pattern diet includes
consumption of fewer fruits and vegetables and increase in processed meals like pizza,
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hamburgers, French fries, dessert and cured meat, and the hypothesis was that population could
be more susceptible to respiratory disease and asthma due to omission of dietary antioxidants.
Fish oil. One explanation for the increased prevalence of asthma during the last three decades
may be the increased consumption of dietary polyunsaturated fats rich in omega 6 (n-6), causing
an imbalance in the n-6:n-3 ratio with too much n-6. Fish oil is rich in omega 3 (n-3) fatty acid
and its potential anti-inflammatory effect is the two active ingredients, EPA (eicosapentaenoic
acid) and DHA (docosahexaenoic acid) which inhibit the formation of leukotrienes and
prostaglandins from arachidonic acid reducing inflammation response. Omega 6 in contrast tend
to promote inflammation.
In a case-control study a group of children were identified as cases with current asthma at
6 or at 8 years of age or as controls with no asthma. Dietary details from birth to 6-8 years old
including n‐6 and n‐3 fatty acid intake data were collected by parent response to a questionnaire
when the children were 6-8 years old. Oddy (2004), reported that foods rich in n-3 fatty acids
and low in n-6 fatty acids provide a more balanced ratio that protects against asthma. Contrary of
this results, in a meta-analysis of nine randomized controlled trials, to determine the effect of
marine n-3 fatty acid (fish oil) supplementation in asthma, the authors reported that “there was
no consistent protective effect of fish oil with any of the analyzable outcomes: FEV1, peak flow
rate, asthma symptoms, asthma medication use or bronchial hyper reactivity” (Thien, De Luca,
Woods & Abramson, 2002). Furthermore , a clinical trial with supplementation of a novel
nutritional formula (NNF) combining fatty acids [EPA and g-linolenic acid (GLA)] , fish oil
and a mix of antioxidant vitamins:[ E, C, b-carotene, taurine] and minerals [ zinc, copper,
selenium, molybdenum, and calcium] did not reveal a difference in proportion of asthma-free
days.(Covar,2010).
9

Antioxidants .The substances that are capable of blocking natural, but destructive
oxidation process are named antioxidants. During inflammatory processes in chronic asthma, an
excess of oxygen-derived free radicals are produced. Free radicals are chemical elements that
irritate and inflame tissues and cause excessive immune reactions leading to respiratory tissue
damage and asthma symptoms. Antioxidants help reduce most inflammatory reactions including
asthma and allergies by blocking these free radicals. Subsequent antioxidant studies have
focused on vitamin C, vitamin E, carotenoids, flavonoids, and antioxidant nutrients such as
selenium and zinc to evaluate their potential role in the etiology and treatment of asthma.
Studies investigating the association between dietary antioxidant intake and asthma have
generated inconsistent results for most antioxidants. A meta-analysis of non experimental studies
undertaken to examine the association between dietary antioxidants and risk of asthma from
1966 to 2007 concluded that the antioxidants vitamin C, E and beta-carotene did not significantly
influence the risk of asthma.(Gao, 2008).But contrary to these negative results intervention
studies with vitamin C supplementation have been associated with reduction of the duration and
intensity of bronchoconstriction. For example, in a randomized, placebo- controlled doubleblind crossover trial with eight asthmatic participants, Tecklenburg (2007) reported that vitamin
C supplementation attenuated the decrease of lung function test Forced Expiratory Volume in
one second (FEV1) after exercise and decreased the levels of proinflammatory eicosanoids in
urine (Leucotirenes and prostaglandin D2). Similarly, Fogarty (2006) showed that vitamin C
supplementation reduced the use of inhaled corticosteroid in asthmatic patients, even though no
improvement in asthma symptoms emerged. In addition, Al-Jawad (2010) showed that serum
levels of malondialdehyd (a biomarker of oxidative stress) in patient treated with Allopurinol,
Selenium, Zinc sulphate, Garlic oil, Vitamin E, Vitamin C, and combination of vitamin E and C
10

were significantly reduced. Also, values on lung function tests like Forced expiratory Vital
Capacity (FVC) and FEV1 were improved. Even though in a meta-analysis of nine randomized
controlled trials analyzed in 2008, the reviewers conclude that there is no evidence that vitamin
C has a specific role in the treatment of asthma. (Kaur, Rowe & Arnols, 2009).This inconsistent
results might be related with poor method of randomization, small sample size, allocation and
blinding was not always clear which could bias the results. Thus the effect of vitamin C
supplementation in asthma might be beneficial but findings from controlled trials have been not
conclusive.
Recently, a meta-analysis has been published reporting the role of vitamin A, C, E, D,
and Mediterranean diet on asthmatic children. (Nurmatov, Devereux & Sheikh, 2011). The
systematic review included 62 studies from 1988 to May 2009.Although, no randomized
controlled trials were found, the studies included, cohort, case-control, cross-sectional or
ecologic designs. A meta-analysis showed that high maternal dietary vitamin D and E intakes
during pregnancy were protective for the development of wheezing outcomes. Also,
Mediterranean diet was protective for persistent wheeze and atopy. For vitamin “E”, three cohort
studies showed higher maternal vitamin E intake in diet during pregnancy were associated with a
reduced risk of wheezing in children at 2 years of age. Two studies, however, reported no
association between vitamin E intake and asthma. Similarly, there was no association between
zinc measurements or vitamin C and early wheeze or asthma-related outcomes. Thus the
available epidemiologic evidence is weak respect to vitamins A, C and E; zinc, and a
Mediterranean diet for the prevention of asthma. Experimental studies of these exposures are
now warranted.
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In contrast to the findings for vitamin A, C and E results for vitamin D were more
consistently positive associated with asthma , specifically, the meta-analyses showed that high
maternal dietary vitamin D intakes during pregnancy protected for their children from
developing wheezing at 2 years old : average OR=0.56, 95% CI[ 0.42-0.73] (Nurmatov, 2011).
Recent studies reported that vitamin D deficiency is associated with an increased
incidence of asthma symptoms in children (Litonjua, 2007). The potential benefit of vitamin D in
Latin American children has been reported by Bherm (2010) who described that in a sample of
606 Costa Rican children with asthma ,3.4% were deficient (< 20 ng/ml) , and 28% were
insufficient (< 30 ng/ml). In addition vitamin D levels were inversely associated with markers of
asthma and allergy severity.
Prospective studies investigating the association between children’s Vitamin D
status and asthma are sparse. Urashima (2010) reported less frequency of asthma attacks in a
group of children that received supplementation with 1200 UI of vitamin D compared with
children receiving placebo (RR: 0.17; 95% CI [ 0.04, 0.73]; p = 0.006). Also, in a recent study
that included the analysis of serum vitamin D levels in a cohort of children between 4 and 8
years old the authors reported that children with higher serum levels of vitamin D were less
likely to have asthma at 5–8 yr of age (Van Oeffelen, 2011).
In summary, previous research suggests little influence of micronutrients on childhood
asthma. Associations between Vitamin A, C, E, zinc, magnesium and asthma were inconsistent.
Studies show more positive association between vitamin D deficiency and prevalence of asthma
and allergies. So far, evidence is weak mainly originates from observational studies using
nutrient intake data, which is not an accurate measure of nutrient status.

12

Vitamin D
Vitamin D was originally classified as “vitamin” because it was considered essential for
skeleton development and calcium metabolism in the body. However, vitamin D does not meet
the strict definition of a vitamin since it can be synthesized in the body from exposure to natural
sunlight. Instead, vitamin D behaves more like a steroid hormone with diverse physiology
actions. Since 17th century deficiency of vitamin D was associated with rickets in children which
is the failure of mineralization of growing bone and cartilage (Hess, 1929)
Sources of vitamin D. Vitamin D or cholecaliferol (vitamin D3) comes from 2 sources:
exposure to UV-B rays in natural sunlight and dietary intake (Including supplements). Skin
exposed to the ultraviolet B (UVB) rays of sunlight contributes on average over 90% of total
vitamin D in the body. Dietary vitamin D accounts for 10% of the total vitamin D and is
available in two forms: vitamin D2 (ergocalciferol) from plant sources like mushrooms, and
vitamin D3 (cholecalciferol) from animal sources mainly in fresh fish like tuna, salmon, beef
liver, cheese, eggs. Fortified foods provide most of the vitamin D in the American diet as cereal,
orange juice, margarine, and milk .Also, vitamin D can be found as a dietary
supplement.(Hatchock,2007) See Table 1.
Food

Serving

Vitamin D (IU)

Vitamin D (mcg)

Pink salmon, canned

3 ounces

530

13.3

Sardines, canned

3 ounces

231

5.8

Mackerel, canned

3 ounces

213

5.3

Quaker Nutrition

1 packet

154

3.9

Cow's milk, fortified with vitamin D

8 ounces

98

2.5

Soy milk, fortified with vitamin D

8 ounces

100

2.5

Orange juice, fortified w/ vitamin D

8 ounces

100

2.5

Cereal, fortified

1 serving ( 1 cup)

40-50

1.0-1.3

Egg yolk

1 large

21

0.53

Table 1. Foods containing vitamin D .USA compsition database.retrieved at http://ndb.nal.usda.gov/
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Synthesis of vitamin D. Sunlight stimulates the production of vitamin D3 through
ultraviolet-B radiation (UVB) of the skin. A wavelength between 290 to 315 nm of UVB causes
that 7-dehydrocholesterol in the skin is converted to previtamin D3, which at body temperature
thermally converts to vitamin D3. Exposure three times a week during the time that causes a
slight pinkness of the skin (15-20 minutes) is equivalent to ingesting 20,000 UI of vitamin D.
Excessive exposure to UVB degrades previtamin D3 and vitamin D3 into inactive photoproducts
and there is no risk of toxicity for sunlight exposure. ( Holick,2007).Some factors that will affect
the synthesis of vitamin D in the skin are: the skin pigmentation, number of hours spending
outdoors, body mass, season, extended of skin exposed to sunlight, the use of sunscreen or the
geographic location where exposure to UV radiation is reduced.(Matzuoka, 1990, 1991, 1992).

Vitamin D metabolism .Vitamin D obtained from sun exposure (vitamin D 3), diet
(vitamin D 2) and supplements is biologically inert and must undergo into two steps of
hydroxylation process in the body for activation (Fig. 2).The first step occurs in the liver and
converts vitamin D to 25-hydroxyvitamin D [calcidiol; 25(OH) D], the major circulating form of
vitamin D. Later in the kidney the second hydroxylation process occurs and forms 1, 25dihydroxyvitamin D [1, 25(OH) 2D], also known as calcitriol (De Luca, 2004). Calcitriol is the
physiologically active form of vitamin D and will generates biological responses binding with
intracelular receptors in diverse cells.The renal production of calcitriol is also regulated by
plasma parathyroid hormone, serum calcium and phosphorus levels . The D-24-hydroxylase
(CYP24) enzyme induces the elimination of both calcidiol and calcitriol into biologically
inactive, water-soluble sustance to be eliminated in urine. Hydroxylation and activation of
vitamin D is outlined in Figure 2.

14

Figure 2 . Norman, A. W. (2001). Vitamin D. In B. A. Bowman, & R. M. Russell (Eds.), Present knowledge in
nutrition (8th ed., pp. 146). Washington, DC: ILSI.

Vitamin D status. Traditionally, the main role of vitamin D has been reported in relation
with bone health promoting the normal absorption of calcium from the gut, but recent studies
have described, nonskeletal roles for vitamin D in human health, including a potential role in
cardiovascular disease, diabetes, cancer (Mohr, 2008, 2011; Wang, 2008; Holick , 2004). Also,
recent studies showed that vitamin D might be reduced the development of asthma and improve
asthma symptoms.
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Serum concentration of 25(OH) D is the best indicator of vitamin D status. It reflects
vitamin D produced cutaneously and that obtained from food and supplements and has a fairly
long circulating half-life of 15 days (Jones, 2008).
Deficiency of vitamin D in children was defined as a serum 25(OH) D level of
27.5nmol/L (<= 10ng/ml) by the Institute of Medicine (1997) based in healthy bones. More
recently in 2008, the Lawson Wilkins Pediatric Endocrine Society, defined vitamin D deficiency
as a serum 25(OH) D level of 37.5 nmol/L (<= 15 ng/ml) (Misra,2008) to avoid rickets.
However no specific serum levels have been defined based in effects on asthma.
According with this classification , results of the National Health and Nutrition
Examination Survey (NHANES) 2001-2004 reported that 9 % of the study sample (7.6 million
children across U.S), were vitamin D deficient, and Mexican Americans, were 3.5 more likely to
have vitamin D deficiency when compared with non-Hispanic white children.
Vitamin D and medication use .Certain medication might interfere with the catabolism
and bioavailability of vitamin D, e.g., anticonvulsants, corticosteroids, rifampin, and
cholestyramin (Walker-Boone, 2004; Di Munno, 2004); however, there is conflicting evidence
confirming this association (Paterson, 2011; Lee, 2010). The impact of medication use on
vitamin D status in these studies was evaluated only in adult population.
Vitamin D intake recommendation . In 2003, the American Academy of Pediatrics
(AAP) recommended 200 UI of vitamin D supplement per day in infants who do not consume
vitamin D–fortified formula. Then in 2008 the AAP recommended to double to 400 IU of
supplemental vitamin D daily for healthy infants, children, and adolescents based on evidence
from clinical trials in the pediatric and adolescent population (Wagner, 2008). More recently, the
Society of Endocrinology suggest that infants and children aged 0–1 yr require at least400 IU of
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vitamin D daily, children 1 yr and older require at least 600 IU/d and, to raise the blood level of
25(OH)D above 30 ng/ml may require at least 1000 IU/d of vitamin D. Even though the dose
recommended for nonskeletal health benefits is not known at this time (Holick, 2011) .
Vitamin D and immune response . Previous studies have shown that vitamin D has an in
vitro potent anti-inflammatory effect that could represent an effective treatment to improve
asthma control by blocking the cascade of inflammation (Szodoray, 2008). Mathew (2003)
reported that vitamin D supressed inflammatory pulmonary response by reducing recruitment of
eosinophils and level of cytokines (IL-5) in the airways. Also, vitamin D has been shown to
inhibit in vitro immune cells like T-cells, monocytes, and macrophages and also to reduce the
allergic response by inhibiting cytokines such as IL-2, IL-12. In addition, Vitamin D enhanced
glucocorticoid action in vitro and in peripheral blood from asthmatic patients. ( Fieri, 2011). Lin
(2004) reported that vitamin D is a potent immune system modulator because vitamin D
receptors (VDR) are present in the main cells of the immune system, which participate in asthma
inflammation cascade including T cells and antigen-presenting cells, such as dendritic cells and
macrophages. (Lin,2004). A recent study showed that vitamin D inhibits LPS-induced p38
activation and cytokine production in monocytes/macrophages (Zhang, 2012).
Vitamin D and asthma. The causes of asthma are a complex interaction of genetic factors
and environmental exposures (Reed, 2006) the influence of dietary factors has generated
growing interest because of their potential impact on airway inflammation which is the core
pathogenesis condition of childhood asthma (Burns 2007 ; Romieu 2005).Even though recent
studies showed that low serum levels of vitamin D may be associated with poor asthma control,
there is controversy, however, about what should be a healthy level of 25-hydroxyvitamin D
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(25[OH]D) for children and what level of 25(OH)D should be used to define vitamin D
deficiency in relation with immune or allergic diseases.
Several studies has been reported the association of vitamin D with the development of
asthma. Litonjua and Weiss (2007) first suggested that the rise in asthma could be partly
explained for vitamin D deficiency in pregnant women and their newborn. Also other authors
reported that maternal vitamin D intake during pregnancy has been inversely associated with
asthma symptoms in early childhood (Camargo & Deverux, 2007). Erkkola (2009) also found
that higher maternal vitamin D intake during pregnancy was associated with a reduced risk of
asthma in 5-year-old children. An important limitation in these studies is that none of them
measured serum 25 (OH) D, which is a much more reliable measure of vitamin D status.
One of the first studies that did measure 25(OH) D reported inconsistent findings. In a birth
cohort study, conducted in New Zealand, low cord blood levels of 25(OH) D levels were
associated with increased respiratory infections and childhood wheezing but not with asthma
diagnosed at age 5.(Camargo, 2011). Also, Gale (2008) reported that children whose mothers
had higher 25(OH)-vitamin D concentration in pregnancy had an increased risk of eczema at 9
months and asthma at 9 years old.
In addition, researchers have focused on examining the relationship between vitamin D
and asthma severity in populations diagnosed with asthma. Black (2005) reported a doseresponse relationship between the serum concentrations of 25-hydroxyvitamin D and improves
of lung function test (FEV1) in adult population. In a cross-sectional study of Costa Rican
asthmatic children, the authors found that high vitamin D levels were associated with reduced
rates of hospitalization, use of anti-inflammatory medication, and increased airway
responsiveness of methacholine (Brhem, 2009).
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A few studies have been reported evaluating Vit D supplementation and asthma.
Hypponen (2004) reported that regular high dose (≥ 2,000 IU/d) vitamin D supplementation
during infancy was associated with an increased likelihood of atopy and allergic rhinitis at 31
years. Contrary to this result, in a recent study Urahima (2010) reported that daily
supplementation with 1200 IU Vitamin D over 3 months showed a decrease in asthma attacks in
children. It is also possible that the long follow-up period on Hypponen’study contributed to
recall bias, which could affect estimates of the association.
Although research studies might support positive effects of vitamin D in asthma, the
inconsistency of the findings from these studies emphasizes the need for further research in this
area to clarify the association of vitamin D status and asthma and allergy.
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Chapter 3. Research Problem
Knowledge about environmental factors that contribute as inducers, modulators, or
triggers of asthma is rapidly expanding (Reed, 2006). One such modulating factor is the antiinflammatory action of micronutrients, many of which are lacking in modern diets. Specifically
it has been suggested that changes in dietary habits associated with a western lifestyle,
particularly diets that are deficient in antioxidants and Vitamin D, may be contributing to the rise
in asthma and allergy prevalence (Weiss, 1997). Vitamin D acts as a modulator by blocking the
cascade of inflammation. The anti-inflammatory effects in vitro suggest that vitamin D may play
role in the clinical manifestation and asthma severity.
However, knowledge about the modulation effect of vitamin D is still incomplete and we
know little about how vitamin D serum levels relate to frequency of asthma symptoms and
clinical exacerbations. Observational studies have reported that vitamin D deficiency might
increase allergic diseases and asthma symptoms; however, more studies are needed to evaluate
the relationship between 25(OH) vitamin D and allergic response especially among those with
established asthma. Particularly because changes in behavioral patterns in urban cities, where
children tend to live and play indoors, as well as cultural practices that tend towards sun
avoidance and widespread use of sunscreens, wearing clothing that covers the skin, long winter
season like in dessert areas or dark skinned persons are factors that influence low production of
natural vitamin D.
The proposed study will address this research gap by examining whether vitamin D
serum levels are associated with asthma symptoms, exacerbations and allergic immune response
in a national sample of children as well as subsamples of several ethnic groups. The outcome of
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the proposed study will be to provide information that can be used to design strategies for
tailored public health intervention to improve asthma control, possible by vitamin D
supplementation. The long term goal is increase the understanding of the association between
vitamin D, allergic sensitization and asthma symptoms.
Hypothesis and Specific Aims
Although previous research has evaluated the association of vitamin D and asthma
symptoms, a limitation of this work is the lack of quantified serum levels of vitamin D taken.
There are still some unanswered questions. Perhaps the most important are whether vitamin D
levels are related to asthma prevalence and severity, and if vitamin D levels are associated with
atopy/allergy. The NHANES contains information related with serum levels of Immunoglobulin
E which plays an important role in the development of allergic asthma and it provides a good
opportunity to examine the potential association between serum levels of vitamin D, IgE and
asthma symptoms for a representative large number of children including Hispanic population.
The overall objective of the proposed study is to describe levels of serum vitamin D and
its relationship to asthma prevalence and asthma symptoms in a representative national sample.
The central hypothesis is that higher serum levels of Vitamin D will be associated with fewer
exacerbations of disease. The hypothesis was formulated based on current understanding of
immune system effects (Griffin, 2003).

21

Mediator (M)
IgE
se
Inflammatory
cascade

_

+
_
Asthma diagnosis
Asthma exacerbations
& Atopy

Serum levels of
25(OH) D

IV (X)
Figure 3. Causal Model –Mediation.

The hypothesis will be tested by analyzing the following specific aims:
Aim1. Determine the association of asthma diagnosis and vitamin D serum levels in children.
Hypothesis1. Levels of vitamin D will be inversely associated with asthma diagnosis.
Aim2. Assess the association between serum levels of 25-Hydroxyvitamin D3 (25(OH)D, which
is an indicator of vitamin D status, and asthma symptoms and allergy.
Hypothesis2. Levels of vitamin D will be inversely associated with symptoms of poorly
controlled asthma in children, as measured by emergency room visits and days absent
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from school for asthma and allergy symptoms.
Aim3. Assess the association between serum levels vitamin D (25(OH) D, and allergic
sensitization measured by serum IgE levels.
Hypothesis3. Levels of vitamin D will be inversely associated with high levels of
Immunoglobulin E.
Aim 4.Test whether IgE serum levels mediate the association between vitamin D status and
asthma exacerbations.
Hypothesis 4.Significant indirect effect will emerge between vitamin D levels, IgE levels and
asthma diagnosis and asthma exacerbations.
Aim5. Explore whether the mediated associations hold for girls and boys and BMI.
The expected outcomes obtained from this study will provide evidence of the potential
effect of Vitamin D in asthmatic children, and the mediation effect of IgE. Findings are expected
to have positive impact leading to the implementation of public health interventions that seek to
reduce vitamin D deficiency in order to improve health among children with asthma.
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Chapter 4.Methods

Study population and sample size

The current study uses data obtained from the National Health and Nutrition Examination
Survey (NHANES) 2005-2006.The study includes 1884 children between the ages of 6 and 15
years old, who were voluntarily enrolled in the survey between 2005 and 2006. The priority
population of NHANES is the civilian, non-institutionalized population of US. The NHANES
includes all races /ethnicities. By selecting school-age children, the study will reach the age
group with whom asthma occurs most frequently.
Overview of Study Design
The purpose of this quantitative secondary analysis is to describe the relationships among
vitamin D status (independent variable), asthma symptoms, and allergic response (dependent
variables) in children, and to test models of its proposed mechanism of action. The study will
involve a secondary analysis of 1884 surveys using 40 variables from the National Health and
Nutrition Examination Survey (NHANES), which include: serum levels of vitamin D,
sociodemographic variables, medical conditions, tobacco exposure and allergens serum test. See
Table 2 for a complete list of variables and their potential role in the study.
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Table 2.

NHANES variables to be used for the examination of vitamin D and asthma/allergy.
Variable
Independent variable
Vitamin D
Dependent variables (First outcome)
Asthma Diagnosis

Detail

Coding

ng/ml

continuous

Has a doctor or other health
professional ever told {you}
that {you have} asthma?

Dichotomous : yes/no

Current asthma

Do you still have asthma?
(Only asked when affirmative
answer to ever having a
diagnosis of asthma)
During the past 12 months,
have you had to visit an
emergency room or urgent
care center because of
asthma?

Emergency visits for asthma

Dichotomous : yes/no

Dichotomous: yes/ no

Asthma attack

During the past 12 months,
have you had an episode of
asthma or an asthma attack?

Dichotomous:yes/no

Wheeze

In the past 12 months have
you had wheezing or
whistling in your chest?
In the past 12 months how
many times have you gone to
the doctor’s office or the
hospital emergency room for
one or more of these attacks
of wheezing ?
During the past 12 months,
how many days of
school did you miss due to
wheezing ?
Detail
Has a doctor or other health
professional ever told {you}
that {you have} asthma?

Dichotomous: yes/no

Medical visits
for wheezing

Missed school
due to
wheezing
Dependent variable (second outcome)
Allergy Diagnosis

Allergy
symptoms
Hay fever
symptoms
Eczema

During the past 12 months,
have you had any allergy
symptoms ?
During the past 12 months
have you had an episode of
hay fever?
During the past 12 months
have you had an episode of
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Continuous (frequency)

Continuous (frequency)

Coding
Dichotomous : yes/no

Dichotomous: yes/no

Dichotomous:yes/no

Dichotomous:yes/no

eczema?
Total IgE

Continuous and Dichotomized <
or >100
kU/L (0,1)

kU/L
Specific IgE
D. farinae (dust mite)
D. pteronyssinus (dust mite)
Cat
Dog
Cockroach
Alternaria (mold)
Peanut
Egg
Milk
Ragweed
Ryegrass
Bermuda
White oak
Birch
Shellfish
Aspergillus (mold)
Thistle
Mouse
Rat
Potential modifiers or confounding
Age at diagnosis
Gender
Race/ethnicity

Household
income
Education of household head

Body mass Index

Environmental Tobacco Smoking
exposure
Time indoors

kU/L
Dichotomized < or >0.35
Ku/L for each
allergen
(0,1)

Detail
Years of age at diagnosis
Females,male
Non-hispanic white
Non-hispanic black
Mexican American
Reported as a range value in
dollars
level of school you completed
or the highest degree you
have received?
weight in kilograms
divided by height in meters
squared.

Serum cotinine
Over the past 30 days
how many hours
did you watch TV/videos?
Over the past 30 days, on
average how many hours per
day did you use a computer
or play computer games
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Coding
continuous
Dichotomous ( 1:M;2:F)
categorical

categorical
Categorical:
Less than HS
HS, incl. GED
More than HS
Categorical
Normal weight
Overweight
obese
Continuous or
dichotomize < or >.015ng/ml
Continuous
None
1-2
≥3
Continuous :
None
1-2
≥3

Detailed Methodology.
The National Health and Nutrition Examination Survey (NHANES) is a nationally
representative survey conducted periodically in the United States by the National Center for
Health Statistics, which is part of the Centers for Disease Control, and Prevention (CDC), and
the resulting data are publicly available. The objective of the survey is to assess the health and
nutritional status of adults and children in the US. The survey combines interviews and physical
examinations. There are two parts to this survey: the home interview and the health examination.
Written informed consent from each participant, for both the in-home interview and the health
exam are taken. For children under age 16, the questionnaire information is collected from a
proxy respondent, typically a parent. The medical examination data includes anthropometric
measurements and laboratory data from assays done on blood drawn at the visit. Other medical
information, including medical histories and symptom information are collected during an
interview. During the in-home interview participants were asked questions about health status,
disease history, and diet. The health examination was performed in a mobile exam center (MEC),
which travel to locations throughout the country. The study team consists of a physician, medical
and health technicians, as well as dietary and health interviewers. Many of the study staff is
bilingual (English/Spanish).
The information used was access by the Center of Disease Control and Prevention website,
there were links that allowed viewing the documentation: questionnaire section, laboratory
component, or exam component. The data files was released as SAS transport files in .xpt format
and converted to SPSS files.
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Variables
Independent variable. 25- Hydroxyvitamin D3 , 25 (OH) D serum levels. NHANES
laboratory files contain information about serum levels of vitamin D, 25 (OH) D. Vitamin D is
derived mainly from cutaneous synthesis in the presence of ultraviolet sunlight while dietary
intake constitutes a minor fraction. Serum 25(OH) D is the best indicator of vitamin D status. It
is converted in the kidney, stimulated by parathyroid hormone (PTH), to the hormonally active
metabolite 1, 25dihydroxyvitamin D (1, 25 (OH) 2D). A blood sample of 300-500 uL / 12+ 104
ml (3.4 ounces), 7.0 tablespoons was taken by a certified phlebotomist. Levels were determined
using Diasorin (formerly Incstar) 25-OH-D assay at National Center for Environmental Health.
A detail description of the laboratory method can be found at web page:
http://www.cdc.gov/nchs/data/nhanes/nhanes_05_06/vid_d_met_vitamin_d.pdf.
Dependent variables are:
Asthma outcomes. Main outcome measures were a) self-reported asthma diagnosis ;
b) asthma exacerbations measured by self-reported wheezing, emergency visits for asthma, and
asthma attacks, all of which are dichotomous (yes/no) variables.Also number of days of medical
visits for wheezing and missed school days due to wheezing were analyzed as continuous
variables.
All participants were administrated the Medical Conditions Questionnaire which asks
participants and parents if they have been told by a doctor that they have asthma. For those with
such doctor-diagnosed asthma, there is complementary information about age of diagnosis of
asthma, if they still have asthma, and if they had asthma attacks, and emergency room visits for
asthma in the past 12 months. Information regarding days absent from school for asthma was
also included. The Respiratory Health and Disease questionnaire collects information also about
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wheezing symptoms and health care and medication use for wheezing attacks, and how much
time they missed from school due to wheezing. Children whose parents answered affirmative to
the questions, “Has a doctor ever told you that you had asthma?” and “Do you still have asthma?
were included in order to evaluate the association of serum levels of vitamin D and
exacerbations of asthma .Specific variables and values are shown in Table 3.
Allergy outcomes. Secondary outcomes of atopy were evaluated as c) self-report allergy
symptoms, hay fever, and eczema which were modeled as dichotomous (yes/no) variables. Also,
total and specific Immunoglobulin E were analyzed as dichotomous : < >100Ku/L and < > 0.35
Ku/L respectively. Atopy has been defined as the genetic tendency to develop the classic allergic
diseases: atopic dermatitis or eczema, allergic rhinitis or hay fever, and asthma. Atopy describes
the tendency of a given individual to produce immunoglobulin E (IgE) antibody responses after
the body is exposed to various allergens including otherwise harmless common environmental
proteins such as house dust mite, grass pollen, and food allergens (Casolaro, Georas, Soong &
Oro, 1996).
The NHANES Allergy questionnaire included questions about previous diagnoses of
eczema, hay fever, and allergies. Similarly to asthma diagnosis, for those reporting one of those
allergy diagnosis, further questions were asked regarding age at diagnosis and occurrence of
symptoms in the previous 12 months.
The laboratory data included Specific IgE and total IgE Allergens in serum. Blood
samples were drawn in the in the Mobile Examination Center and referred to Immunology
Laboratory at Elmhurst Memorial Hospital where they were analyzed using the Pharmacia
Diagnostics ImmunoCAP 1000 System (Kalamazoo, Michigan). A detailed description of the
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laboratory method can be found at web page:
(http://www.cdc.gov/nchs/data/nhanes/nhanes_05_06/al_ige_d.pdf).
Children were tested for total IgE as well as nineteen specific IgE to dust mite (D. farinae
and D. pteronyssinus), cat, dog, cockroach, alternaria, peanut, egg, and mil, ragweed, ryegrass,
bermuda, white oak, birch, shellfish, aspergillus, thistle, mouse, and rat. The analysis included
the 19 Specific IgE specific allergen and IgE total .Values of 0.35 kU/L and above represent a
progressive increase in the relative concentration of allergen-specific antibodies. Atopy has been
defined in these analyses as a positive response (≥ 0.35kU/L) to at least one of the allergens
tested.
Covariates. The main covariates of interest include age- and sex-specific percentile BMI,
age, race, socioeconomic status, and education of the parent. Another covariate considered for
inclusion in final models included environment tobacco exposure. Criteria for inclusion were
significant bivariates associations between the dependent variable and the covariates.
Body Measurements-Anthropometry. Children who attended the medical examination
had their weights and heights measured which were then used to calculate Body Mass Index
(BMI) as weight in kilogram divided by height in meters squared. Trained health technicians
performed all of the NHANES body measurements using standardized examination methods and
calibrated equipment.
Weight: The participant stood on a floor scale that was equipped with a digital read-out. All body
weight data were captured electronically and entered into the survey database automatically.
Stature (Standing Height): Height was measured using a wall-mounted stadiometer. Additional
information is available at : http://www.cdc.gov/nchs/data/nhanes/nhanes_05_06/BM.pdf
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For this analysis normal weight, overweight and obesity were defined by using age- and sexspecific percentile curves on the basis of pooled international data defined by Cole et al (Cole,
2000).Table 3.
Table 3 .
Cut off points for body mass index for overweight and obesity by sex between 6 and 15 years, adapted
from Cole et al.(2000).
"Overweight" is a BMI
greater than:

"Obese" is a BMI
greater than:

Age
(years)

Boys

Girls

Boys

Girls

6

17.55

17.34

19.78

19.65

7

17.92

17.75

20.63

20.51

8

18.44

18.35

21.60

21.57

9

19.10

19.07

22.77

22.81

10

19.84

19.86

24.00

24.11

11

20.55

20.74

25.10

25.42

12

21.22

21.68

26.02

26.67

13

21.91

22.58

26.84

27.76

14

22.62

23.34

27.63

28.57

15

23.29

23.94

28.30

29.11

Time Indoors/Sun Exposure. One potential predictor of vitamin D status is the time of
skin exposure to sunlight because sunlight stimulates the production of vitamin D3 through
ultraviolet-B radiation of the skin. So, it is expected that children who spend more time indoors
might have lower vitamin D serum levels. NHANES includes questions regarding the number of
hours spent watching TV/videos and spent on the computer. For the analysis the total hours spent
indoors per week and number of times of vigorous activities were used as indirect estimator of
sun exposure.
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Sample size and Power Analysis
For Aim 1, there were 1884 children between 6 and 15 years old who completed the
medical questionnaire that included asthma diagnosis data and 25(OH) D serum levels.
Considering that national asthma prevalence in children is 10%, and the baseline risk of vitamin
D deficiency is 9%. The study had 90 % power for overall analyses to detect a small effect size
of .095 at alpha =0.05 (See fig.4).

Figure 4. Small effect size at different values of power.
Aim 2.To assess the effect of serum levels of vitamin D on asthma diagnosis data base of
children whose parents reported being diagnosed with asthma (304 children age 6-15) was used .
Considering alpha =0.05, the study had 90% power for overall analyses to detect a medium
0.175 effect size (See fig 5).
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Figure 5. Power at different effect size values.
Statistical Analysis
Data analysis was focused on comparing changes in 25 (OH) D serum levels and doctordiagnosed asthma, frequency of number of visits to emergency room for asthma and days absent
for school for asthma symptoms as a primary outcome. The self-reported diagnosis and
symptoms of allergy, hay fever, and eczema were evaluated as a secondary outcome. Total and
specific level of IgE were used to define atopy in children with a positive result if at least one of
the antigen-specific IgE were higher than .35 Ku/ L. Beyond performing descriptive and
exploratory statistics, serum levels of vitamin D were compared between groups using
correlation, chi-squared and logistic regression. To assess the effect of vitamin D primary and
secondary outcomes across the vitamin D status groups were compared: deficiency 25 (OH) D
≤15 ng/ml, insufficiency = 25(OH) D between 15-29 ng/ml and sufficiency 25 (OH) D ≥ 30
ng/ml. Univariate and multivariate models with adjustment for potential moderators BMI,
tobacco exposure,and gender were analyzed using IBM Statistic s SPSS (V19). A latent variable
was built to evaluate the effect of vitamin D on asthma severity. In addition, mediation analysis
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were performed using the total serum IgE levels as a mediator of the relationship between
vitamin D and asthma and the effect of gender and BMI as potential moderators using AMOS
20.
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Chapter 5. Results

Overview of Study Design
The purpose of this quantitative secondary analysis was to describe the relationships
among vitamin D status, asthma symptoms, and allergic response in children, and to test models
of its proposed mechanism of action. The study involved a secondary analysis of data from 1884
children using 40 variables from NHANES. The survey combines interviews and physical
examinations including laboratory tests. Written informed consent from each participant was
obtained. The questionnaire information was collected from a parent and included self-reports of
asthma and allergy symptoms, sociodemographic variables, medical conditions, and laboratory
measurements of vitamin D,tobacco exposure (cotinine serum levels) , and allergens serum tests.
Data Screening
Prior to analysis, all study variables were examined for data entry, accuracy and missing
values. The minimum and maximum values, means, and standard deviations of each of the
variables were inspected for plausibility. There were 12 variables with missing values. The
missing values observed in these variables were less than 5 % with a maximum percentage of 3.2
%. The Little’s MCAR (missing completely at random) test showed a significance value greater
than .05 (x2=673, p=1.0). Because the null hypothesis for Little’s MCAR test is that the data are
missing completely at random (MCAR) it was concluded that the data were missing completely
at random .The cases with missing data were statistically indistinguishable from those that were
complete (Little, 2002). In order to check for normality, skewness and kurtosis were examined,
and probability plots were generated for each variable. The independent variable: serum levels of
vitamin D revealed slight positive skewness (.427), and slight high kurtosis value (.652) these
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values were within normal distribution range; neither value was severe enough to warrant
transformation of this variable. A strong leptokuric distribution was shown in the specific
allergens serum levels and cotinine.To achieve normal distribution natural log transformation
was used. All other variables showed minimal negative skewness and were well within the
expected values.
Missing data were corrected by mean substitution. The z scores values were created to
test for univariate outliers.Vitamin D included 7 z-scores values > 3.29 related with values ≥
78.80 ng/ ml. To reduce the influence of these outliers, the 7 outlying scores were changed to one
unit larger than the next higher score in the distribution. Cotinine showed 20 scores > 3.29, and
the 19 allergen tests had the number of outliers ranging from a minimum of 5 to a maximum of
30 values. Considering that all values were plausible in the sample, the values were retained and
log transformed.
Sample Characteristics
The sample consisted of 1884 children between 6 and 15 years old who completed
medical questionnaire and who also had results of serum levels of vitamin D. Characteristics of
study participants are shown in Table 4.The average age of the participants was 11.8 (SD=2.8).
The majority was in a normal weight range with a mean Body Max Index (BMI) of 21 kg/m2.
The distribution of gender was almost equal with females making up 49.7% of the participants.
Most of the children (90.1% or 1697), were born in the US. Non-Hispanic blacks and MexicanAmericans were the highest percentage of race because NHANES over-sampled these two
categories to obtain accurate estimates in these sub-populations. Caretaker’s education levels
were mainly high school education or greater. Exposure to environmental tobacco was present in
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the majority of children (78%). The parents reported their children spent an average of 2 hours
watching TV / videos or using the computer daily.
Table 4.
Demographic characteristics of children 6-15 years from NHANES 2005-2006
Variable
Age at screening
Gender
Females
Race/ethnicity
Mexican American
Non-Hispanic Black
Non-Hispanic White
Other, including multi-racial
Other Hispanic
Country of birth
USA
México
Elsewhere
Annual Household income
median category
Education of household head
Less than 9th grade
9-11th Grade
High School Grad/GED
Some College or AA degree
College Graduate or above
Body Mass Index
Tobacco Smoking exposure
Serum cotinine ng/ml
Non tobacco exposure ≤.014
Tobacco exposure ≥ .015ng/ml
Time indoors
Average hours of TV/videos /d
Average hours of computer/d

N
1884

Mean (SD)
or percentage %
11.8 (2.8)

947

49.7%

656
572
490
113
53

34.8 %
30.4%
26.0%
6.0%
2.8%

1697
132
55

90.1%
7.0%
2.9%

1884

35,000 to 44,999

237
347
475
503
322
1884

12.6%
18.4%
25.2%
26.7%
17.1%
21.03 (5.58)

1884
419
1465

2.6 (22.3)
22.2%
77.8%

1884
1884

2.17 (1.87)
1.99 (2.29)
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Asthma Status
Table 5 shows the diagnosis and severity of self-reported asthma symptoms among the
sample of children age 6-15 years NHANES 2005-2206. Sixteen percent of the participants
(n=304) had been diagnosed with asthma by a health professional in their lifetimes (i.e.,
asthmatic children) and ten percent reported current asthma (n= 202). Of those diagnosed with
asthma, 264 (87%) had suboptimal serum levels of vitamin D (< 30ng/mL).
The frequency of asthma attacks and wheezing, number of medical visits , number of
emergency room visits, disturbed sleep due to wheezing, and missed school days due to asthma
were analyzed. Half of the children with current asthma required medical visits for wheezing
attack during the past year. Also, 50% of asthmatic children reported missed days from school
because of wheezing. Most of the currently asthmatic children had 2 or 3 episodes of wheezing
attacks during the last year.
Table 5
NHANES variables to be used for the examination of vitamin D and asthma.
Asthma variables
Have ever been told you had asthma (N=1884)
Yes

N

Mean (SD) or %

304

16.1 %

304

4.8 (3.7)

202

66.4 %

Had asthma attack in past year (N=202)
Yes

111

55 %

Emergency visits for asthma last 12 months( N=111)
Yes

31

27.9 %

Wheezing in chest past year (N=1884)
Yes

202

10.7 %

Number of wheezing attack past year (N=202)
One
2 to 3
≥4

202
58
89
55

3.4 (3.2)
28.7 %
44.1 %
27.2 %

Age when first had asthma (N=304)
Current asthma (N=304)
Yes
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How many times got medical attention for wheezing attack in
the past year (N=202)
None
≤ 3 times
≥ 4 times
Disturbed sleep because of wheezing (N=202)
Yes

84
99
19

41.6 %
49.0 %
9.4 %

120

59.4 %

Miss days from school because of wheezing (n=202)
Yes

104

51.5%

Allergy Status
Allergy status was determined in two ways: a questionnaire about allergy symptoms and
measurement of total IgE and antigen-specific IgE levels. The NHANES 2005-2006
questionnaire assessed allergic symptoms. Table 6 shows the responses to the questions of ever
been diagnosed with allergy, hay fever, and eczema by a health professional in lifetime, and
occurrence of symptoms associated with one of those diagnoses. One fourth of the children had a
previous diagnosis of allergy. Even though the percentage of those with a diagnosis of hay fever
was low (4.1%), a much greater proportion (23%) reported many of the main symptoms of it
(e.g., runny nose, sneezing and blocked nose without the presence of viral infection).
Table 6
NHANES variables to be used for the examination of vitamin D and Allergy
Allergy variable
Doctor told had allergies (N=1884)
Yes
Had Allergies symptoms in past year (N=457)
Yes
Doctor told had hay fever ( N=1884)
Yes
Hay fever symptoms in past year (N=78)
Yes
Sneezing or a runny, or blocked nose when
{you/s/he}did not have a cold or the flu. (N=1884)

N
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(%)

457

24.3

306

67

78

4.1

60

76.9

Yes
Doctor told have Eczema (N=1884)
Yes
Atopic ( at least one specific IgE >.35 Ku/ L
Yes

438

23.2

220

11.7

902

47.9

Children were tested for IgE total and 19 antigen-specific IgE levels (Table 7). A positive
result or “atopic” classification was made if at least one of the antigen-specific IgE were higher
than .35 Ku/ L. Given this criterion, half of the population showed a positive specific IgE result
and were classified as atopic (47.9%). The most common allergen sensitizations overall in the
children’s population were Ryegrass at 24%, D. pteronyssinus (dust mite) at 22%, and D. farinae
(dust mite) at 21%.

Table 7
Specific IgE Allergen: perennial allergy and food allergy
Specific IgE Allergens

N=1884
Mean (SD)
195.7 (427.5)
6.13(40.8)
6.8 (42.2)
1.87 (15.7)
1.45(15.69)
1.08(7.15)
1.48(6.95)
1.09 (10.5)
.28(.48)
.31(.28)
1.67(13.9)
9.0(50.7)
4.27(28.4)
3.0 (21.9)
3.0 (21.9)
.68(7.68)
.74(3.0)
1.28(8.23)
.53(4.23)
.30(1.01)

Total IgE Ku/L
D. farinae (dust mite)
D. pteronyssinus (dust mite)
Cat
Dog
Cockroach
Alternaria (mold)
Peanut
Egg
Milk
Ragweed
Ryegrass
Bermuda
White oak
Birch
Shellfish
Aspergillus (mold)
Thistle
Mouse
Rat
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Positive allergy
( >.35 Ku/L) %
21.7
22.3
13.4
15.9
13.4
13.0
12.2
4.3
10.5
17.5
24.0
19.4
16.0
14.0
8.1
11.2
15.1
3.3
1.4

Bivariate Analysis
Association between demographic characteristics and 25 (OH) D
Table 8 shows correlations among key demographic variables and Vitamin D levels. As
shown, Vitamin D correlated with all demographic variables except time spent on computer.
Common characteristics associated with higher vitamin D levels include younger age, male,
lower BMI, greater annual income, and less time watching TV.

Table 8
Characteristics and Serum Vitamin D levels: Correlations (N = 1884)
1
1. Vitamin D (ng/mL)

2

3

4

5

6

7

-

2. Age

-.29**

-

3. Sex (1 = M; 2 = F)

-.10**

.00

4. Body Mass Index (kg/m2)

-.32**

5. Annual Household Income

.16**

-

.42** .07**
.04

-.04

-.13**

-

6. # hours watch TV or videos past 30
days
7. # of hours use computer past 30 days

-.15**

.02

-.03

.12**

-.10**

-.12**

-

-.02

.00

-.02

.02

-.14**

-.14**

.08**

**. Correlation is significant at the 0.01 level (2 tailed).

Characteristics of participants based on Vitamin D status
The majority of study children had serum vitamin D levels of less than 30ng/ml, with
mean ± SDs of 22.13 ± 7.8 ng/mL. The average of Vitamin D concentrations were slightly
higher in boys compared with that in girls (23 vs. 21 ng/mL, p<.001). Children were classified
into three groups based on Vitamin D levels: sufficient (≥30 ng/mL), insufficient (15-29 ng/mL),
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or deficient (< 15 ng/mL). These classifications are important because of their clinical relevance.
How these categories related to other study variables is included in Table 9.While many of the
results reflect the correlational analysis presented above, there are some interesting clinical
implications, particularly for bone health. For example, nearly two-thirds (64.2%) of the
children had insufficient levels of vitamin D. Deficient levels of vitamin D were presented in
20% of the children, and were significantly associated with ethnicity: non-Hispanic blacks had
the lowest levels (57% of the deficiency category were non-Hispanic black), older age and
female sex (60%) were also associated with deficient level of Vitamin D. In underweight and
normal weight children, the prevalence of vitamin D deficiency was 16.3% (n = 261), while
overweight children had a prevalence of 35.1% (n = 66), and obese children had a prevalence of
51.6% (n = 49) showing that deficiency of vitamin D is higher with the increased of BMI. .
Children whose parents had less than a high school education showed lower percentages of
sufficient serum levels of vitamin D when compared with children whose parents´ education was
greater than high school. Finally, the category of deficient vitamin D was related with higher
percentage of children with tobacco exposure (82%) and watching television for more than four
hours per day (29%).
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Table 9
Characteristics of children by vitamin D status
Variable

11(2.8)

Deficiency
1-15 ng/ml
376 (20)
n ( %)
12.50 (20.0)

25 (OH) D
Insufficiency
16-29ng/ml
1209 (64.2)
n(%)
10.96 (64.2)

Sufficiency
≥30 ng/ml
299 (15.9)
n( %)
9.82 (15.9)

All children
1884
n ( %)

X2, F

Age, mean (SD)
Gender
Females
Males
Race/ethnicity
Hispanic (Mexican-American)
Non-Hispanic Black
Multi-racial

84.42*

947(50.3)
937(49.7)

229(24.2)
147(15.7)

578(61.0)
631(67.3)

140(14.8)
159(17.0)

21.36*

709 (37.6)
572 (30.4)
113( 6.0 )

135 (19)
214(37.4)
16(14.2)

502 (41.5)
332( 58.0)
76 (67.3)

72 (24.1)
26 (4.5)
21(18.6)

371.5*

Country of birth
USA
Mexico
Elsewhere

1697(90.1)
132(7.0)
55(2.9)

342(91)
25(6.6)
9(2.4)

1076(89)
95(7.9)
38(3.1)

279(93.3)
12(4.0)
8(2.7)

6.30

Household income , mean categ. (SD)
Parental education
< 9th – 11 thgrade
12th grade/GED
>12th grade

7.34 (3.0)

6.69(2.8)

7.31(3)

8.27(2.84)

25.5*

584 (31.0)
475( 25.2)
825 (43.8)

134(22.9)
97(20.4)
145(17.6)

384(65.7)
297 (62.5)
528 (64.0)

66(11.3)
81(17.1)
152 (18.4)

16.9*

Body Mass Index (kg/m2) , mean (SD)

21.03 (5.5)

24.08(6.6)

20.71 (5.1)

18.46(3.9)

99.0*

Tobacco Smoking exposure ( cotinine

2.66 (22.3)

2.86 (17.6)

2.97 (25.7)

1.16(17.9)

0.44

Non tobacco exposure ≤0.014
Tobacco exposure ≥.015ng/ml

419(22.2)
1465(77.8)

65(15.5)
311(21.2)

282(67.3)
927(63.3)

72(17.2)
227(15.5)

6.74

Time indoors
Hours / day watching TV
Hours/ day use a computer

2.17 (1.4)
1.99(2.2)

2.49 (1.5)
2.01(2.1)

2.15 (1.4)
2.03(2.3)

1.82(1.3)
1.83(2.3)

17.8*
0.88

ng/ml)

* The mean or proportion difference is significant at the 0.05 level.
significantly at the .05 level.
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b

=proportions that differed

Associations between Asthma Measurements and 25 (OH) D
To assess Aim 1: Logistic regression and chi-square analyses examined relationship
between vitamin D, asthma diagnosis and asthma symptoms (Fig.6). These analyses were
performed using continuous values of 25(OH) D and the three categories of vitamin D as
independent variables. All outcomes were dichotomous. The results of these analyses are shown
in Table 9. As expected, lower values of vitamin D were associated with a greater likelihood of
being diagnosed with asthma, however this effect only approached significance for the
continuous vitamin D variable (OR=.98, p=.053) but was not significant for the chi-square
analysis (p = .11).Self-reported symptoms of asthma, number of days absent from school due to
wheezing and number of emergency visits for asthma attack were not associated with 25(OH) D
as continuous or categorical variable (Table 10).

Aim1. Determine the association of asthma diagnosis and vitamin D serum levels in
children.

25 (OH) D

Asthma diagnosis &
asthma symptoms

Model 1
Fig.6. Asthma diagnosis and 25(OH)D model
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Table 10. Self-reported Asthma by Vitamin D status
Variable

N

Univariable
analysis by
25(OH)D
OR

1-15 ng/ml
(%)

X2

25 (OH) D
16-29ng/ml
(%)

≥30 ng/ml
(%)

Asthma
Asthma Diagnosis
Yes
No
# wheezing past year
Yes
No
Miss school days due to
wheezing
Yes
No
Got medical attention
because of wheezing
attack
No
Yes
Wheezing disturb sleep
past year
No
Yes
Had asthma attack p/y
No
Yes
Emergency visits for
asthma past year
No
Yes
+

304
1580
1884
202
1682
202
104
98

.98+

72 (23.7)
304 (19.2)

192(63.2)
1017 (64.4)

40(13.2)
259 (16.4)

4.26

.98

52(25.7)
324(19.3)

119(58.9)
1090(64.8)

31(15.3)
268 (15.9)

4.80

.97

31(29.8)
21 (21.4)

57(54.8)
62 (63.3)

16(15.4)
15 (15.3)

1.98

16 (19)

54(64.3)

202
84

.98

118
202
82
120
202
91
111
111
80
31

14(16.7)
3.37
17(14.4)

36(30.5)

65(55.1)

19(23.2)
33(27.5)

52 (63.4)
67(55.8)

11(13.4)
20(16.7)

1.02

24 (26.4)
25(22.5)

57(62.6)
67(60.4)

10(11)
19(17.1)

1.65

.96

14 (17.5)
11 (35.5)

52 (65.0)
5(48.4)

14(17.5)
5(16.1)

4.25

1.00

1.22

= p = .053

Allergy Diagnosis, Allergy Symptoms and 25(OH) D:
To assess Aim 2: The association of Allergy variables with serum levels of vitamin D,
similar logistic regression and chi square analyses were performed. As shown in Table 11, lower
levels of vitamin D were associated with greater odds of being diagnosed with an allergy, being
diagnosed with hay fever, and atopic status (i.e., positive allergen test). Diagnosis of an allergy
was significantly greater (23 % vs 13 %) in the group with deficient (< 15 ng/mL) vitamin D
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than in the group with sufficient serum levels of 25(OH) D. The odds ratio between episodes of
hay fever and 25 (OH) D was significant in logistic regression showing that for one nano
gram/milliliter decrease in serum levels of 25(OH) D, the risk of an episode of hay fever
increased by 8.2%. In addition, participants classified as atopic by a positive allergen specific
IgE showed high proportions of lower levels of vitamin D than non-atopic (23 % vs 16%).

Table 11
Self-reported Allergy symptoms by Vitamin D status
Variable

Allergy
No
Yes
Episode of Hay fever
N=78
No
Yes
Allergy symptoms
N=457
No
Yes
Sneezing, running
nose and blocked nose
N=1884
No
Yes
Itchy rash past 6 months
N=1884
No
Yes
Atopic
No
Yes

Ln IgE Total IgE Ku/L

N

Univariable
25 (OH) D
analysis by
1-15 ng/ml
16-29ng/ml
25(OH)D
n (%)
n (%)
OR
Allergy symptoms

X2
≥30 ng/ml
n (%)

1428
456

.98*

269(18.8)
107 (23.5)

920(64.4)
289(63.4)

239 (16.7)
60(13.2)

6.55*

18
60

.91*

2(11.1)
17(28.3)

13(72.2)
38 (63.3)

3(16.7)
5(8.3)

N/R

151
306

1.02

44(29.1)
63(20.6)

85(56.3)
204 (66.7)

22(14.6)
39(12.7)

5.13

232(16)
67(15.3)

.47

1447
437

.99

284(19.6)
92(21.1)

931(64.3)
278(63.6)

1724
160

.99

345 (20.0)
31(19.4)

1102(63.9)
107(66.9)

277(16.1)
22(13.8)

.72

982
902

.97*

160 (16.3)
216 (23.9)

651 (66.3)
558 (61.9)

171 (17.4)
128 (14.2)

18.31*

1884

-.07**

4.33(1.52)

4.13(1.53)

3.95(1.47)

5.21*

N/R = Not calculated because 2 cells < 5
 Significant <.05 ** correlation significant <.01
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Association between IgE, and Vitamin D [25(OH) D]
To assess Aim 3: To evaluate the association between serum levels of vitamin D [25(OH)
D], and allergic sensitization measured by serum IgE level a series of statistical analyses was
performed. Lower mean values of IgE were found in the group of sufficient vitamin D (≥
30ng/ml) than in the group with deficient vitamin D status (<15ng/ml) (See Table 11). Because,
immunoglobulin E results showed considerable skewness, natural logarithm (ln) transformation
was used to reduce the influence of potential outliers and normalize the distributions. Next,
associations between continuous (log transformed) IgE outcomes and 25(OH) D were evaluated
by correlations. These analyses were also done using logistic regression. To do so, serum levels
of 25(OH)D were evaluated as continuous and as categorical variable with Immunoglobulin E
also as a categorical variable classified as “atopic” or “no atopic” if any specific IgE was
>0.35Uk/L.
Table 12 shows the results of the correlation analysis, whereas Table 13 shows the
logistic regression analyses. As Table 12 shows, vitamin D correlated negatively with total IgE
levels and fourteen of the IgE values for the specific allergens.
Logistic regression showed that increasing values of vitamin D correspond with 5% of
decreasing odds of being atopic: Exp (B) =.974, p<.001. Immunoglobuline E was also positively
associated with asthma and allergy diagnosis and symptoms (Table 13).
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Table12
Correlations between 25(OH) D, total IgE and allergen-specific IgE
Variable
r
Variable
r
IgE (natural log
transformed)
-.39**
Food allergens
Peanut
-.09**
Perennial allergens
Ragweed
-.09**
Egg
.01
Rye grass
-.11**
Milk
.00
Bermuda grass
-.10**
Shrimp
-.09**
Oak
-.09**
Birch
-.08**
D. Farinae
-.09**
D. Pteronyssinus
-.10**
Cat
-.04
Dog
-.07**
Cockroach
-.13**
Alternaria
-.09**
Aspergillus
-.09**
Thistle
-.09**
Mouse
-.05*
Rat
-.02
** Correlation is significant at the .01 level (2-tailed). *Correlation is significant at the .05 level (2-tailed)

Table13. Correlations between IgE and selected variables measuring Asthma and Allergy
ASTHMA

IgE_ln ( r )
N=

Asthma
diagnosis

Wheezing
past year

Current
asthma

Emergency
visits
wheezing

0.19
1884

0.15
1884

0.14
304

0.35
111

0.12
1884

0.19
1884
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Doctor
told have
hay fever

Doctor
told
have
allergies

ALLERGY
Sneezing
in past
12
months
0.17
1884

Ever
had
itchy
rash
0.05
1884

Doctor
told
have
eczema
0.09
1884

Asthma Predictors: Multivariate Analysis:
Multivariate logistic analyses examined factors associated with asthma diagnosis. For
these analyses being diagnosed with asthma by a health professional in their lifetimes (asthma
diagnosis) served as the main outcome variable and serum levels of vitamin D, atopic status, sex,
parental education, tobacco exposure, ethnicity, hours watching TV, hours using a computer,
family income, serum levels of Immunoglobulin E and BMI served as predictors. The outcome
was categorical; the predictors included both categorical and continuous variables.Stepwise
regression was chosen because the entry of variables was based on statistical criteria. The
advantage of stepwise selection is that an interpretable model will be created containing the most
important predictors. The results are shown in Table 13.
The univariate model (see column 1) shows the bivariate associations between asthma
diagnosis and potential predictors.The risk of being diagnosed with asthma was greater among
the group of deficient serum levels of vitamin D, atopic children, males, children whose parents
had a higher education level, children with older age, increase IgE serum levels, and overweight
and obese children assessed independently in univariate analysis (Table 13).
Model 1 followed examination of univariate relations, a stepwise regression entered predictor
variables into the logistic regression equation one at a time based upon statistical criteria of p
≤0.15 in univariate models. Tobacco exposure, which is considered an important component for
physiologic reasons, was also included. Results indicated that deficient serum levels of vitamin
D, atopic status, male sex, and parental education all significantly increased the odds of positive
diagnosis of asthma. Ethnicity, income and hours watching TV or using a computer remained no
significant and were removed for the next model.
Model 2 incorporated the variables of age, IgE serum levels and the category variable of weight
as normal weight, overweight and obese to predictors included in Model 1. Results indicated that
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male sex, parental education, higher levels of IgE and being obese all significantly increased the
odds of positive diagnosis of asthma. Serum levels of vitamin D, and atopy became nonsignificant.All the variables significantly associated with asthma (p <0.05; Model 2) were
entered into Model 3.
Model 3 shows that the strongest predictors related to a positive diagnosis of asthma were
obesity,children’s whose parents had higher years of education,had higher levels of
Immunoglobulin E, and being male sex when controlling for tobacco exposure and age (Table
14).

Table 14
Multivariate Logistic regression of asthma diagnosis by selected covariates
Univariate
Mutivariate
Variable
Model 1
Model 2
OR
(95% CI)

p

p

OR
(95% CI)

OR
(95% CI)

Model 3
p

OR
(95% CI)

p

25(OH)D
Sufficient
(≥30ng/mL)

1.00
1.22 (.84-1.76)

1.00
.28 1.30(.88-1.93)

1.00
.17 1.10 (.75-1.62)

.60

1.53 (1.00-2.33)

.04 1.64(1.02-2.65)

.04 1.24 (.78-1.96)

.35

Atopic

2.17(1.68-2.80)

.00 2.09 (1.61-2.71)

.00 1.24 (.90-1.69)

.17

Gender: male

1.45 (1.13-1.86)

.00 1.43(1.11-1.85)

.00 1.33 (1.02-1.72)

.02 1.31 (1.01-1.69)

.20 1.22 (.85-1.76)

1.00
.27 1.34 (.94-1.93)

1.62 (1.20-2.18)
1.11(.82-1.50)

.00 1.50 (1.05-2.15)
.48 1.13 (.81-1.57)

1.07 (.98-1.16)
.95 (.90-1.00)

Insufficient
(15-29 ng/mL)
Deficient
(< 15 ng/mL)

Parent Edu
< 9th
1.00
HS or GED 1.25 (.88-1.77)
>12th
Tobacco
exposure
Hours comp
Hours TV

.03

.10

1.00
1.35( .94-1.93)

.10

.02 1.69 (1.24-2.32)
.45 1.09 (.80-1.50)

.00
.56

1.71 (1.25-2.33)
1.11(.81-1.52)

.00
.50

.10 1.07 (.98-1.17)

.09

1.05 (.97-1.15)

.19

.09 .95 (.90-1.01)

.13

.95 (.90-1.01)

.11
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Income

1.02(.98-1.06)

.21 1.00 (.95-1.05)

Age

1.04(.99-1.09)

.05

1.01 (.96-1.06)

.55 1.02 (.97-1.07)

.30

IgE_ ku/L

1.41 (1.30-1.54)

.00

1.33 (1.20-1.47)

.00 1.39 (1.281.52)

.00

BMI (kg/m2)
Underweight
Normal

1.00
2.01 (.96-4.21)

.06

1.00
1.79 (.83-3.86)

.13

1.74 (.81-3.74)

.15

Overweight

2.45 (1.09-5.54)

.03

2.20 (.93-5.23)

.07

2.25 (.95-5.31)

.06

Obese

3.43 (1.44-8.14)

.00

2.70 (1.07-6.82)

.03

2.81(1.12-7.05)

.02

Race
Hispanic
White

.96 (.54-1.70)
1.21 (.68-2.17)

.89
.50

Black

1.42 (.80-2.52)

.22

Multiracial

.79

1.00

Allergy Predictors: Multivariate Analysis:
Multivariate logistic analyses examined factors associated with allergy diagnosis. For
these analyses ever been diagnosed with allergy by a health professional (allergy diagnosis) was
defined as the main outcome variable and serum levels of vitamin D, atopic status, sex, parental
education, tobacco exposure, ethnicity , hours watching TV, hours using a computer , family
income, serum levels of Immunoglobulin E, and BMI served as predictors. The outcome was
categorical; the predictors included both categorical and continuous variables. The results are
shown in Table 14.
The univariate model (see column 1) shows the bivariate associations between allergy
diagnosis and potential predictors.The risk of being diagnosed with an allergy was greater among
the group of deficient serum levels of vitamin D, atopic children, those with parental education
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higher than elementary school, Hispanic children, higher family income, higher IgE serum
levels, and greater BMI assessed independently in univariate analysis (Table 15).
Model 1 Following examination of univariate relations, a stepwise regression entered predictor
variables into the logistic regression equation one at a time based upon statistical criteria of p
≤0.15 in univariate models. Results indicated that deficient serum levels of vitamin D, atopic
status, parental education ,serum levels of IgE and being overweight and obese comparing with
underweight children all significantly increased the odds of positive diagnosis of allergy (p
<0.05; Model 1) and were entered into Model 2. The predictors of being Hispanic and income
become non-significant.
Model 2 shows that the strongest predictors of been diagnosis with allergy were the deficiency
of vitamin D (OR=1.48, 95% CI (1.02-2.21), children with higher BMI particularly overweight
children ,those whose parents had higher years of education and had higher levels of
Immunoglobulin E controlling for age (Table 15).
Table 15
Multivariate Logistic regression of Allergy diagnosis by selected covariates
Univariate
Variable

Model 1
OR(95% CI)

p
value

OR (95% CI)

Model 2
p
value

OR(95% CI)

P
value

25(OH)D
Sufficient (≥30ng/mL)

1.00
Insufficient (15-29 ng/mL)

1.00

1.00

1.25 (.91-1.71)

.16

1.39 (.98-1.96)

.39

1.24(.89-1.72)

.19

Deficient (< 15 ng/mL)

1.58 (1.10-2.27)

.01

1.79(1.15-2.78)

.00

1.48 (1.02-2.21)

.04

Atopic

2.50 (2.01-3.12)

.00

1.78 (1.35-2.35)

.00

1.74(1.32-2.28)

.00

.83 (.67-1.03)

.10

.92 (.73-1.15)

.47

Gender: male
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Parent education
< 9th
HS or GED
>12th
Tobacco
exposure
Race
Hispanic
White
Black
Multiracial

1.00

1.00

1.00

2.27 (1.63-3.03)

.00

2.27 (1.64-3.16)

.00

2.50 (1.82-3.43)

.00

2.55 (1.93-3.36)

.00

2.37 (1.71-3.27)

.00

2.74(2.06-3.65)

.00

1.26(.97-1.64)

.08

1.28 (.95-1.72)

.09

.78 (.48-1.26)

.31

1.05(.65-1.71)
.81(.50-1.30)
1.00

.82
.38

.59(.38-.93)

.02

.90 (.57-1.42)
.98(.62-1.53)
1.00

.66
.94

Annual family income

1.05(1.01-1.08)

.00

1.02(.98-1.07)

.21

Age

1.02(.98-1.06)

.22

.98(.94-1.02)

.41

.98 (.94-1.03)

.54

IgE_Log ku/L

1.35(1.26-1.45)

.00

1.23(1.12-1.34)

.00

1.22(1.12-1.34)

.00

BMI (kg/m2)
Underweight

1.00

1.00

1.00

Normal

2.74(1.40-5.34)

.00

2.81 (1.39-5.66)

.00

2.86(1.43-5.74)

.00

Overweight

3.04(1.46-6.32)

.00

3.32(1.51-7.27)

.00

3.27(1.50-7.11)

.00

2.94(1.24-6.97)

.01

2.86(1.22-6.72)

.01

3.00(1.34-6.37)

.00

Obese
Hours computer

.99(.94-1.04)

.75

Hours TV

1.02(.95-1.09)

.58

Model Test: Measurements Model
Structural equation modeling (SEM) is a statistical technique that combines factor analysis
with multiple regressions and path analysis. Overall, these twin techniques allow researchers to
reduce the dimensionality of the data among observed variables and to eliminate substantial
measurement error by creating latent variables to represent constructs of interest. In general,
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measurement models are constructed and evaluated first, before testing of structural models.
Measurements models evaluate how well multiple indicators represent a construct, whereas
structural models examine relationships among constructs.
In the present study, these techniques were used to examine a number of hypotheses, each
reflected in by its own model. These hypotheses included the inverse association between serum
levels of vitamin D with asthma severity.SEM also allowed us to analyze the indirect effect of
vitamin D on asthma severity through the effect of Immunoglobulin E. All structural equation
analyses were performed using SPSS AMOS v. 20.0
Measurement Model for Asthma Severity
The first model builds the relationship between the concept of interest (e.g., asthma severity)
and indicators designed to measure that specific concept. To do so, a latent variable severity was
created using covariance among the observed variables: wheezing events, visits to doctor’s office
for wheezing, days absent for school because of wheezing and disturbed sleep for asthma
symptoms as indicators of asthma severity. The fit of this measurement model was good: Chisquare: χ2 (5) = .387, p = .99, CFI = .99 and RMSEA = .05. The four indicators had significant
factor loadings (>.60), medical visits because of wheezing were the best indicator of asthma
severity (.88). See Figure 7.0. So, it was concluded that the measurement model fits and could be
used in subsequent structure model analysis.
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Figure 7. Measurement model of Asthma severity
Structural Models
The association between vitamin D and asthma severity was evaluated using a structural
model in AMOS 20.0. Asthma severity served as a latent variable in this analysis; however, since
there was only one indicator of Vitamin D, it was treated as an observed variable. The fit of the
model was satisfactory with χ2 (5) = 13.7, p = .01, CFI = .99, and RMSEA = .03. However, as
shown, the path from vitamin D to asthma severity only approached significance with a
standardized regression coefficient of -.04 (SE=.003), p=.07(Figure 8).
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Figure 8. Structural model vitamin D and Asthma severity.

Mediation Analysis Asthma: Aim 4 stated that a significant indirect effect will emerge
between vitamin D levels, IgE levels and asthma symptoms. To test whether IgE serum levels
mediate the association between vitamin D status and asthma, a mediational path analysis model
was tested. This model included direct testing of the indirect effect using bootstrapping methods
to estimate the parameter and construct confidence intervals for it (Cheung, 2008). 5,000 samples
were requested and confidence interval (CI) was created for the mediational path, ab.
For this analysis, the mean estimate of the ab path was -.013, 95% CI [-.023,-005]. In this
case, both the a and b coefficients were statistically significant: a= -.07, p<.05; b= .17, p<.05).
Moreover, the bootstrapped CI for ab did not include zero and can be used to judge the
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significance of the indirect path. By these criteria, the indirect effect of vitamin D on asthma
severity through IgE was statistically significant. Overall the net indirect effect was negative
suggesting that asthma severity symptoms is less likely to be present by .013 units for every 1
unit increase in vitamin D if one considers the indirect influence via Immunoglobulin E. The
direct path from vitamin D to asthma severity was not statistically significant: r=-.03, p=.19.
Inspection of model reveals all of the traditional indices of overall fit were satisfactory (CFI =
0.99, RMSEA = 0.02).
Moderation Analysis Asthma: Moderation of this effect by gender was tested by estimating the
model with separate groups of males and females and use of the Chi-Square difference test to
evaluate whether estimating the regression weights separately for the two groups significantly
increases model fit. To do so, a baseline chi-squared value was computed for the pool variables
of all groups (females and males) χ2 (19) = 56.4. Any parameter that is assigned a label will be
constrained by AMOS to be equal across groups. So, a constraint were add one at the time for
path a (vitamin D and IgE), path b (IgE and asthma severity), and path c (vitamin D and asthma
severity), yielding a chi-square for boys and for girls value for the constrained model . The
analysis show that only the path between IgE and asthma severity improved model fit ( i.e.,
differ for males and females),with a significant difference between the original (χ2 (19) = 56.4)
and the constrained-equal models ( χ2 (18) = 44.2) = ( χ2 (1) = 12.2 ,p < .001. No differences
were found with BMI. This analysis suggests that the indirect effect of vitamin D and asthma
severity meditated by IgE was moderated for gender. The association between IgE and asthma
severity is strongest for boys (r=.22) than for girls (r=.09). See Figure 9.
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Indirect effect =a x b=-.08 X.17=-.013*
(B = .22, G=.09)

Figure 9.Structural mediation model.Indirect effect of vitamin D and Asthma severity through
IgE.
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Chapter VI: Discussion
The overall objective of the proposed study was to describe levels of serum vitamin D
and its relationship to asthma / allergy diagnosis (Aim 1) and asthma/ allergy symptoms (Aim 2).
Also, this study assessed the association between vitamin D and allergic sensitization measured
by total serum IgE and specific-allergen IgE levels (Aim 3). Also, in order to evaluate whether
IgE serum levels were responsible for the association between vitamin D status and asthma
symptoms, Immunoglobulin E was examined as mediator in the relationship of vitamin D and a
latent variable severity (created using covariance among the observed variables: wheeze events,
visits to doctor’s office for wheeze, days absent for school because of wheezing and disturbed
sleep from asthma symptoms) (Aim 4).Finally, the study examined if that relationship differed
(i.e., was moderated by) for gender and BMI (Aim 5).
The main study hypothesis that lower serum 25(OH) D would be associated with
increased risk of asthma diagnosis by a health professional was confirmed. The risk of asthma
was 53% higher among children with deficient serum levels of 25(OH) D compared with
children with sufficient vitamin D status (OR, 1.53; CI, 1.00-2.33). However, this association
was weak and became non-significant after adjusting the model for age, race, tobacco exposure,
parental education and atopy. This effect might be explained because vitamin D may be related
to the covariates that explains some of the process underlying the reasons why vitamin D relates
to asthma diagnosis.
Allergy diagnosis was also associated with vitamin D deficiency (OR, 1.58; 95% CI
(1.10-2.27). After adjusting the model for age, gender, parental education and BMI the odds
ratio remained significant (OR, 1.48; CI, 1.02-2.21). Similar to asthma diagnosis, however,
these associations were modest in size. The present study showed that higher serum levels of
58

IgE which is the proven test for allergy detection were also associated with lower levels of
vitamin D (r (1882) = -.39, p < .01) with a higher prevalence of sensitization to most allergens.
Finally, logistic regression analyses showed that deficient vitamin D levels were associated with
higher likelihood of being atopic (OR, 1.80; CI, 1.32-2.45).
The mediation analysis showed that vitamin D was negatively related to asthma severity
and that Immunoglobulin E mediated this relationship. Specifically, there was a net negative
indirect effect such that vitamin D was related to IgE and that IgE was in turn related to asthma
severity. Moderated-mediation analyses suggested that gender moderated this association.
Specifically this analysis showed that the relationship between IgE and asthma severity was
stronger for boys than girls. This suggests that there could indeed be an inflammatory component
to the association between vitamin D and asthma and that this effect is stronger among boys than
girls.
Although there was an association between deficiency of vitamin D with higher risk of
asthma diagnosis vitamin D deficiency was not related to severity of asthma symptoms
(frequency of wheezing, number of medical visits, number of emergency room visits, disturbed
sleep due to wheezing, and missed school days due to asthma). There may be several reasons for
this surprising result. The lack of significance could be the result of an inaccurate (i.e., invalid)
measurement of asthma symptoms. For this variable we rely on parent’s report of asthma
symptoms during the last 12 months, which could not be a reliable measurement of children’s
asthma symptoms due to problems associated with recall bias (Kieckhefer, 2009). Even though
the parent’s report about a diagnosis from a doctor or a health professional could have also recall
bias, it tends to be more accurate than asthma symptoms report (Canova, 2011).
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Most studies have found negative associations or no association between vitamin D levels
and asthma symptoms and diagnoses. The inverse association between vitamin D and asthma
diagnosis in the present study is consistent with Alyasin (2011) who found in a case-control
study that decreased vitamin D levels were associated with significantly increased risk of
asthmatic state in 100 children aged 6-18 years. Also, Brehm (2009) reported that higher serum
25(OH) D concentrations were associated with less hospitalization because of asthma in a crosssectional study of Costa Rican children. Other authors suggested a protective effect of vitamin D
in the frequency of asthma symptoms by reducing the use of asthma medication (Searing, 2010).
Contrary to that, Xiao-Mei (2012) found no association between serum levels of vitamin D and
asthma in adult population. In a recent case control study of 236 children, asthma severity had no
relationship to 25(OH) D levels.This design had a potential for a selection bias as the children
were included on the basis of serum vitamin D data availability which represented only 7% of
the asthmatic children (Menon,2012). So, the present study using a national representative
sample suggests that vitamin D deficiency may increase the risk for development of asthma. It is
recommended that clinical trials be conducted to explore these inconsistencies.
Similar results have been found for allergy where deficiency of vitamin D has been
related with a higher risk of allergy diagnosis. This observation is consistent with other studies
(Bhrem, 2009; Ehlayel, 2011; Hollams, 2011). Also, findings in a birth cohort study of
Australian children showed that vitamin D levels at age 6 were protective against the presence of
rhinitis and atopy at age 14 (Hollams, 2007). In addition, Frieri (2011) reported that vitamin D
deficiency was positively correlated with prevalence of allergies using the same data from
NHANES 2005-2006. The difference with the present study is that the Frieri included only adult
participants whereas the present study adds to this literature by finding similar associations
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among children. But, the evidence of an association between vitamin D and allergy is
inconsistent, Gale (2008) reported that children whose mothers’ serum levels of vitamin D were
high than >30 ng/mL during pregnancy had an increased risk of eczema at 9 months old.
Hyppoten et al. (2009) suggested a threshold effect of vitamin D, reporting that both low and
high 25(OH) D were associated with increased IgE concentrations in a long birth cohort
completed at 45 years old. During the present analyses it was found that only low vitamin D
levels were consistently associated with an increased risk of allergy using both measurement of
allergy status: allergy self-reported symptoms and serum IgE levels (atopy).
One of the novel findings of this study is the significant mediation effect of IgE in the
relationship of vitamin D and asthma severity. No other studies were identified that evaluated
IgE as a mediator in the relationship between vitamin D and asthma diagnosis. However,
previous studies support these findings. Milovanovic( 2010) reported that vitamin D inhibits the
IgE production through the vitamin D receptor (VDR) in a laboratory study using human B cells
as the possible underlying mechanisms. Other authors have linked the potential reduction of
asthma and allergic diseases by vitamin D trough the effect on cells that intervenes in the cascade
of inflammation like the dendritic cell and the induction of interleukin (IL)-10-producing CD4+
CD25+ regulatory T-cells leading to a potential reduction on IgE (Xystrakis,2006;
Gorman,2010). This study performed in children population support those findings in laboratory
studies. Combined, these studies suggest that one of the possible mechanisms by which
deficiency of vitamin D increase the risk of asthma is through the lack of reduction of IgE
leading to the development of immune and allergic conditions. The present study provided
several interesting findings in addition to the examination of the main hypothesis. For example,
the prevalence of asthma (16.3%) observed in this cross-sectional study was higher than that
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reported for U.S. children (9.5%) using similar self –reported asthma questions (Akibami, 2012).
The high prevalence observed may be due to the sample design. NHANES includes
oversampling to obtain reliable estimates of health and nutritional measures for population
subgroups (i.e. non-white-blacks) and traditionally this ethnic group had the higher asthma
prevalence. As such, the current sample would have to be weighted in order to be useful for
population-based epidemiology.
Another interesting finding related to changes in vitamin D levels over time.
Specifically, the prevalence of insufficient serum levels of vitamin D (>16 and < 30 ng/ml) and
deficient serum levels of vitamin D (< 15 ng/ml) differed from those using previous NHANES
(2001-2004) data that used similar oversampling procedures. The prevalence of insufficient
vitamin D increased 3% from 61% in NHANES 2001-2004 (Kumar, 2009) to 64% in NHANES
2005-2006. Similarly, the group of deficient serum levels of vitamin D (< 15 ng/ml) increased
11% from 9% in 2001-2004 to 20% in 2005-2006. This may reflect that more children are not
getting enough of vitamin D it in their diet and/or they are not going outside enough to prevent
vitamin D deficiency .The growing awareness of skin cancer avoiding the sun exposure and the
growing tendency to maintain children indoors may explain the increase prevalence of vitamin D
deficiency in children (Linos, 2012).Also, in this analysis vitamin D deficiency was associated
with higher BMI. Several biological and behavioral factors might influenced this results .The
potential mechanisms proposed in the literature are a reduced bioavailability of vitamin D due to
a sequestration of vitamin D in adipose tissue . Also, the reduction of serum 25-OHD in obese
population is attributed to an increase synthesis rate of 1,25(OH)2D, the biologically active form
of vitamin D, leading to a feedback inhibition of hepatic synthesis (Bell,1985). In addition, obese
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children tend to have a more sedentary lifestyle avoiding outdoor activities and sunlight exposure
which is necessary for adequate synthesis of vitamin D (Blum, 2008).
Moreover, these vitamin D levels related to asthma in the present study showed that
overall, 86% of asthmatic children had levels below an accepted optimal threshold < or =30
ng/mL (23% was deficient and 63% insufficient ). The deficiency of vitamin D was
considerably higher than that reported by Brehm et al. (2009) who found that 25% of asthmatic
children in Costa Rica had vitamin D levels <30 ng/mL, and only 3.4 % had levels <20 ng/mL.
More recently, Searing (2011) reported that 47% of pediatric patients with asthma had VitD (<30
ng/mL) and 17% were in the group of (<20 ng/mL). Those studies differ in their definition of
vitamin D deficiency (<20 ng/mL vs 16 ng/mL in the present study). In addition, the differences
could be related to a differences population with a combination of dietary, genetic, and
environmental factors (e.g., time spend indoors, clothing coverage, sunscreen use, latitude, skin
pigmentation) that influence the vitamin D concentrations. Thus, the conclusion is that
prevalence of vitamin D deficiency among asthmatic children seems to reflect a greater
percentage in NHANES population but no valid conclusions could be made as many factors
might be influenced the variation across different children population.
Finally, this analysis identified the predictors of asthma in this sample. The predictors for
asthma diagnosis in addition to vitamin D deficiency were atopy, being male, higher parental
education and obesity.
Others studies support atopy condition as one of the strongest factor for developing
asthma (NHLBI, 2009). Also, obesity was associated with higher risk of being diagnosed with
asthma, and the association was stronger for the obese category than for the overweight category
consistently reported for other authors (Flaherman, 2006; Shore,2008; Wen-Chao,2011). Several
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mechanisms that may explain the relationship between asthma and obesity are that both
conditions are associated with inflammation by increased levels of inflammatory cytokines and
other markers, such as leptin and C-reactive protein. Also obese children had reduced lung
volume and are more susceptible to inflammation leading to airway narrowing. Findings about
parental education are consistent with a recent case-control study in which higher parent
education was associated with asthma (Bener, 2012). Non evidence had been found about the
possible causes, but it could be inferred that children with better- educated parents may have
more access to health care, then increasing the opportunity to being diagnose with asthma. In a
recent meta-analysis of 79 longitudinal studies, exposure to passive smoking increased the
incidence of wheezing and asthma in children by approximately 20 % (Burke, 2012). In the
present study, a high percentage of children had tobacco exposure measured by serum cotinine
values (78%) indicating that they had been involuntarily exposed to tobacco smoke. Even though
no significant association were found between tobacco exposure and asthma in this sample, lack
of measurement of temporally exposure and outcome in this cross sectional analysis could
influence the results. The protection of children from exposure to tobacco smoke should be
strengthened and expanded.
In this study the approach was to evaluated serum levels of vitamin D as a potential risk
factor for asthma prevalence and frequency of symptoms. Asthma is a multifactor and complex
disease in which several factor like infections, toxicants, nutrition, genetics, and social
environment may interrelate and contribute to the disease development. So, intervening to
prevent the development of asthma will require multi-level strategies and policies.
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Limitations
The NHANES data comes from a cross-sectional survey; it is not possible to assign
causality to these associations. In order to test true causal mechanisms that underlie the
relationships between vitamin D and asthma and allergic symptoms, it will be necessary to
examine the relationships among vitamin D, IgE, with asthma and allergy in a prospective study.
Cross-sectional studies may be subject to reverse causality, for example, where parents or
children with respiratory conditions such as asthma or allergic symptoms avoid outdoor activities
and subsequently receive less sunlight exposure.
The asthma and allergy outcome measures come from self-report rather than an objective
medical diagnosis. The potential parent’s underreporting of asthma symptoms is a limitation
when they asked to recall the events during long periods of times like 12 months. Vitamin D
deficiency was defined by one-time single measurement of serum 25 (OH) D but this value may
not represent a long-term vitamin D status for children. So the conclusions could not be true for a
long period of time. The lack of information about season or month of blood collection could not
establish all season and long-term vitamin D status in the studied population.
Strengths
NHANES 2005-06 comes from a representative sample that is potentially generalizable
to the population of the US. NHANES has the experience and capability of employing highly
trained personal, and employs standardized data collection methods with strict quality control.
To select the sample, a multistage, probability sample design was used. There was no selection
of children based on pre-diagnosed asthma and could represent best any link between vitamin D
levels, and symptoms of allergy and asthma. NHANES 2005-2006 is a largest data measurement
of vitamin D in children. The serum concentrations of 25(OH) D serve as a more reliable method

65

for determining vitamin D status. Previous studies of asthma and vitamin D were based on only
dietary recall questionnaires. Serum vitamin D levels reflect circulating levels including both
from diet and from skin synthesis. NHANES 2005-2006 also incorporates a new model of
allergy containing the measurement of total and specific IgE and allows for examination of
whether an allergic mechanism may be involved in the association of vitamin D and asthma.
Future Directions
This study supports the hypothesis that deficiency of vitamin D is a risk factor for asthma
and allergy and suggests that IgE is a potential mediator of this relationship .However, the
optimal level of vitamin D that decreases the risk remains unidentifiable. Future studies will need
to define appropriate levels without using predetermined cutoffs in the analyses. A more accurate
measurement of vitamin D status should incorporate the measurement at different time points
including different seasons. Also, more evidence is needed it about whether vitamin D
contributes during the development of immune system (unborn and early ages of life) or during
the manifestation of the disease. Randomized control trials are required to assess the effects of
vitamin D supplementation on the fetal lung, the developing immune system, and their possible
role in preventing the asthma and allergy symptoms. The new information about the mediation
effect of IgE in the relationship of vitamin D with asthma contributes to knowledge of potential
mechanism by which vitamin D may be protective in asthma and allergic diseases.Further
investigation is needed to confirm the association and to fully understand the role of IgE.
Conclusions
Asthma is the most common chronic disease in children and a growing public health
problem in the U.S. and around the world. Many risk factors had been associated with asthma,
but none of the previous efforts had been successful in controlling and reducing this
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multifactorial disease. Recent evidence links the increase of deficiency of vitamin D with more
allergic disease. The main objective of this study was to understand the relationship and potential
mechanisms by which vitamin D affect asthma and allergy. The NHANES is a large national
database that employs standardized data collection procedures generalizable to the U.S.
population. Using an objective measure of vitamin D status and atopy (IgE), it was found that
deficiency of vitamin D in children appears to be associated with higher likelihood of asthma and
allergy in children,and particularly in asthma this effect of vitamin D is mediated by IgE levels.
Reduction of vitamin D deficiency could be a potential public health strategy to decrease asthma
and allergy severity among children.
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